Robustness of CT radiomic features against image discretization and interpolation in characterizing pancreatic neuroendocrine neoplasms.

[1]  R. Steenbakkers,et al.  The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping. , 2020, Radiology.

[2]  Jie Lu,et al.  Reproducibility and non-redundancy of radiomic features extracted from arterial phase CT scans in hepatocellular carcinoma patients: impact of tumor segmentation variability. , 2019, Quantitative imaging in medicine and surgery.

[3]  E. S. Durmaz,et al.  Influence of segmentation margin on machine learning–based high-dimensional quantitative CT texture analysis: a reproducibility study on renal clear cell carcinomas , 2019, European Radiology.

[4]  R. Gillies,et al.  Repeatability and Reproducibility of Radiomic Features: A Systematic Review , 2018, International journal of radiation oncology, biology, physics.

[5]  J. Canales‐Vázquez,et al.  Radiomics of CT Features May Be Nonreproducible and Redundant: Influence of CT Acquisition Parameters. , 2018, Radiology.

[6]  Qianjin Feng,et al.  Robustness versus disease differentiation when varying parameter settings in radiomics features: application to nasopharyngeal PET/CT , 2018, European Radiology.

[7]  Dengwang Li,et al.  Reproducibility of radiomic features with GrowCut and GraphCut semiautomatic tumor segmentation in hepatocellular carcinoma , 2017 .

[8]  Philippe Lambin,et al.  4DCT imaging to assess radiomics feature stability: An investigation for thoracic cancers. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  B. Erickson,et al.  Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: An exploratory study , 2017, PloS one.

[10]  Richard Tuli,et al.  Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients. , 2017, Journal of gastrointestinal oncology.

[11]  Lawrence H. Schwartz,et al.  Assessing Agreement between Radiomic Features Computed for Multiple CT Imaging Settings , 2016, PloS one.

[12]  Zaiyi Liu,et al.  Effects of contrast-enhancement, reconstruction slice thickness and convolution kernel on the diagnostic performance of radiomics signature in solitary pulmonary nodule , 2016, Scientific Reports.

[13]  Wolfgang Weber,et al.  Reliability of PET/CT Shape and Heterogeneity Features in Functional and Morphologic Components of Non–Small Cell Lung Cancer Tumors: A Repeatability Analysis in a Prospective Multicenter Cohort , 2016, The Journal of Nuclear Medicine.

[14]  Jiazhou Wang,et al.  Reproducibility with repeat CT in radiomics study for rectal cancer , 2016, Oncotarget.

[15]  Geoffrey G. Zhang,et al.  Combining radiomic features with a miRNA classifier may improve prediction of malignant pathology for pancreatic intraductal papillary mucinous neoplasms , 2016, Oncotarget.

[16]  Ziding Feng,et al.  Quantitative imaging to evaluate malignant potential of IPMNs , 2016, Oncotarget.

[17]  Ronald Boellaard,et al.  Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [18F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation , 2016, Molecular Imaging and Biology.

[18]  Geoffrey G. Zhang,et al.  Variability of Image Features Computed from Conventional and Respiratory-Gated PET/CT Images of Lung Cancer , 2015, Translational oncology.

[19]  N. Thacker,et al.  Quantifying heterogeneity in human tumours using MRI and PET. , 2012, European journal of cancer.

[20]  Patrick Granton,et al.  Radiomics: extracting more information from medical images using advanced feature analysis. , 2012, European journal of cancer.

[21]  M. Hatt,et al.  Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer , 2011, The Journal of Nuclear Medicine.

[22]  T. McDade,et al.  Complications after pancreatectomy for neuroendocrine tumors: a national study. , 2010, The Journal of surgical research.

[23]  A. Rutman,et al.  Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging. , 2009, European journal of radiology.

[24]  T. McDade,et al.  Pancreatic neuroendocrine tumors , 2009, Cancer.

[25]  G. Petersen,et al.  Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  C. Ko,et al.  Prognostic Score Predicting Survival After Resection of Pancreatic Neuroendocrine Tumors: Analysis of 3851 Patients , 2008, Annals of surgery.

[27]  G. Sassolas,et al.  Interest of Chromogranin A for diagnosis and follow‐up of endocrine tumours , 2004, Clinical endocrinology.

[28]  V. Vilgrain,et al.  Prognostic factors in patients with endocrine tumours of the duodenopancreatic area , 1998, Gut.

[29]  Sara Broggi,et al.  Ct radiomic features of pancreatic neuroendocrine neoplasms (panNEN) are robust against delineation uncertainty. , 2019, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.